G6PD and sickle cell disease: From our limited case series, patients with G6PD who are candidates for LVAD implantation must follow a dedicated pathway as those with sickle cell disease should.22 In particular, initially all patients must absolutely avoid postoperative hypoxemia (Spo2 ≤ 90% or a Po2 ≤ 60 mmHg).